Rigakafin cutar thrombosis

Rigakafin ƙwayar cuta ko thromboprophylaxis magani ne na likita don hana haɓakar thrombosis ( jini a cikin tasoshin jini ) a cikin waɗanda aka yi la'akari da haɗarin haɓakar thrombosis.  Wasu mutane suna cikin haɗari mafi girma don samuwar jini fiye da wasu, kamar wadanda ke da ciwon daji da ke yin aikin tiyata.   Yawancin matakan rigakafi ko tsoma baki ana farawa ne bayan tiyata saboda rashin motsin da ke tattare da shi zai kara haɗarin mutum. 

Ana amfani da magungunan jini don hana ƙumburi, waɗannan magungunan jini suna da tasiri daban-daban da bayanan tsaro. Wani bita na tsari na 2018 ya gano binciken 20 wanda ya haɗa da mutane 9771 masu ciwon daji. Shaidar ba ta gano wani bambanci tsakanin illar nau'ikan sinadirai na jini daban-daban akan mutuwa, tasowa guda ɗaya, ko zub da jini ba .  Wani bita na 2021 ya gano cewa ƙananan ƙwayar heparin (LMWH) ya fi heparin mara kyau a farkon maganin thromboembolism na jini ga mutanen da ke fama da ciwon daji. 

Akwai abubuwan da suka shafi magunguna da abubuwan da ba na magani ba.  Ana iya saukar da haɗarin haɓaka ƙwayar jini ta hanyar gyare-gyaren salon rayuwa, dakatar da maganin hana haihuwa, da asarar nauyi . A cikin waɗanda ke cikin haɗari mai girma, ana amfani da su sau da yawa.  Magunguna don hana samuwar ɗigon jini suna daidaitawa da haɗarin zubar jini. 

Ɗaya daga cikin manufofin rigakafin zubar da jini shine iyakance jijiyar jijiyar jini saboda wannan yana da mahimmancin haɗari don samar da jini a cikin zurfin jijiyar kafafu.  Ciwon jijiyoyi na iya faruwa a cikin dogon lokaci na rashin motsi . Hakanan ana ba da shawarar rigakafin thrombosis yayin tafiya ta iska.  Ƙwararrun ƙwayar cuta yana da tasiri wajen hana samuwar jini na jini, masaukin su a cikin jijiyoyi, da kuma tasowa zuwa thromboemboli wanda zai iya tafiya ta cikin tsarin jini don haifar da toshewa da mutuwar nama a cikin wasu gabobin . Brunner L (2010). Brunner & Suddarth's textbook of medical-surgical nursing. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 876. ISBN 978-0-7817-8590-7. Clarence Crafoord an ƙididdige shi da farkon amfani da rigakafin thrombosis a cikin 1930s.

 Manazarta